Quest PharmaTech Inc. (QPTFF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.01 Million CAD | 95.35% |
| 2022 | -64.88 Million CAD | 23.7% |
| 2021 | -85.03 Million CAD | -144.74% |
| 2020 | 190.06 Million CAD | 3185.13% |
| 2019 | -6.16 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -861.32 Thousand CAD | -105.95% |
| 2024 Q2 | 719.56 Thousand CAD | 183.54% |
| 2023 Q2 | -9.81 Million CAD | -9079.49% |
| 2023 Q4 | 14.48 Million CAD | 676.61% |
| 2023 FY | -3.01 Million CAD | 95.35% |
| 2023 Q1 | -106.92 Thousand CAD | 99.83% |
| 2023 Q3 | -2.51 Million CAD | 74.41% |
| 2022 Q3 | -911.13 Thousand CAD | 0.0% |
| 2022 FY | -64.88 Million CAD | 23.7% |
| 2022 Q4 | -62.31 Million CAD | -6739.26% |
| 2021 FY | -85.03 Million CAD | -144.74% |
| 2020 FY | 190.06 Million CAD | 3185.13% |
| 2019 FY | -6.16 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 95.974% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 54.107% |
| SQZ Biotechnologies Company | -79.46 Million USD | 96.202% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 105.697% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 104.634% |
| Mesoblast Limited | -87.95 Million USD | 96.569% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -65.776% |
| Genus plc | 7.9 Million USD | 138.203% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 72.291% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 18.657% |
| Marizyme, Inc. | -65.34 Million USD | 95.382% |
| ContraFect Corporation | -65.15 Million USD | 95.368% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 65.875% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 38.232% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -74.708% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -4.343% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 62.554% |
| MultiCell Technologies, Inc. | -380.07 USD | -793966.093% |
| Accustem Sciences Inc. | -3.74 Million USD | 19.443% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 94.162% |
| EV Biologics, Inc. | -1.26 Million USD | -138.176% |
| Q BioMed Inc. | -2.05 Million USD | -47.07% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 19.153% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -377.225% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -26.761% |
| Biomind Labs Inc. | -1.21 Million USD | -148.535% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | 71.388% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 61.812% |
| Skye Bioscience, Inc. | -37.64 Million USD | 91.983% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -39.091% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -20052.29% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 56.78% |
| IMV Inc. | -36.48 Million USD | 91.728% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 80.985% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 48.12% |
| GB Sciences, Inc. | -1.36 Million USD | -121.639% |
| Alpha Cognition Inc. | -13.77 Million USD | 78.087% |
| HST Global, Inc. | -146.21 Thousand USD | -1964.159% |
| CSL Limited | 2.64 Billion USD | 100.114% |
| Halberd Corporation | -79.67 Thousand USD | -3687.85% |
| Enzolytics Inc. | -2.17 Million USD | -38.642% |
| Resverlogix Corp. | -3.61 Million USD | 16.399% |
| Affymax, Inc. | -14.42 Million USD | 79.076% |
| SYBLEU INC | -180.3 Thousand USD | -1573.844% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 4.838% |
| argenx SE | -295.05 Million USD | 98.977% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 95.179% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 3179.599% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 24.037% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 0.269% |
| AVAX Technologies, Inc. | -6.41 Million USD | 52.944% |
| Zenith Capital Corp. | -10.59 Million USD | 71.517% |
| Genscript Biotech Corporation | -95.47 Million USD | 96.839% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -12885.143% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 27.206% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -4893.343% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 94.947% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 2.7% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -185.781% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -54.829% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 20.974% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -50.515% |
| BioStem Technologies, Inc. | -8.48 Million USD | 64.423% |
| ONE Bio Corp. | 8.67 Million USD | 134.783% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -583.783% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -125.995% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -71.989% |
| Agentix Corp. | -1.37 Million USD | -119.617% |
| LadRx Corporation | 400.44 Thousand USD | 853.667% |
| Cell Source, Inc. | -5.32 Million USD | 43.283% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -626.392% |
| Regen BioPharma, Inc. | 1.02 Million USD | 394.869% |
| Regen BioPharma, Inc. | 1.02 Million USD | 394.869% |
| NovAccess Global Inc. | -4.76 Million USD | 36.719% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 143.584% |
| Itoco Inc. | -1.86 Million USD | -61.478% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 32.066% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -80.827% |
| Kadimastem Ltd | -3.3 Million USD | 8.75% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -1003.872% |
| CytoDyn Inc. | -49.84 Million USD | 93.945% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -3718.667% |
| Mobile Lads Corp. | -2.26 Million USD | -33.346% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -1222.95% |
| Qrons Inc. | -789.34 Thousand USD | -282.342% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -220.543% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -44.563% |
| Rebus Holdings, Inc. | -1.02 Million USD | -195.883% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -87.136% |
| International Stem Cell Corporation | -131 Thousand USD | -2203.822% |
| Bioxytran, Inc. | -4.28 Million USD | 29.486% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -5460.891% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -19.277% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 93.722% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -42.763% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -286.484% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 4.735% |
| Neutra Corp. | -233.46 Thousand USD | -1192.702% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 85.126% |
| PureTech Health plc | -65.69 Million USD | 95.406% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 85.809% |
| IXICO plc | -1.17 Million USD | -156.198% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 69.598% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 94.717% |
| CSL Limited | 2.64 Billion USD | 100.114% |
| Cellectis S.A. | -103.17 Million USD | 97.075% |